ACTA
PHARMACEUTICA
Acta Pharm. Vol. 62 No. 1 pp. 1-122
Zagreb, March 2012
TABLE OF CONTENTS
REVIEW
B. Kovačič, F. Vrečer and O. Planinšek
Spherical crystallization
of drugs. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . 1
ORIGINAL RESEARCH PAPERS
A. H. Mandour, E. R. El-Sawy, M. S. Ebaid and S.
M. Hassan
Synthesis
and potential biological activity of some novel 3-[(N-substituted indol-3-yl)methyleneamino]-6-amino-4-aryl-pyrano(2,3-c)pyrazole-5-carbonitriles and
3,6-diamino-4-(N-substituted indol-3-yl)pyrano(2,3-c)pyrazole-5-carbonitriles. . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. 15
J. Varshosaz, F. Hasanzadeh and M. Eslamdoost
Optimization of self-assembling properties of fatty acids grafted to
methoxy poly(ethylene glycol) as nanocarriers for etoposide. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . .. 31
R. N. Sharma and S. S. Pancholi
Simple RP-HPLC method for determination of triple drug combination of valsartan, amlodipine and hydrochlorothiazide in human plasma. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45
E. S. Ali Ibrahim, S. Ismail, G. Fetih, O. Shaaban, K.
Hassanein and N. Hassan Abdellah
Development and characterization of
thermosensitive pluronic-based metronidazole in situ gelling formulations
for vaginal application. . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .59
M.
Emeje, L. John-Africa, Y. Isimi, O.
Kunle and S. Ofoefule
Eudraginated polymer blends: A potential oral controlled drug delivery system for theophylline. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
Z. Mohammadi, F. A.
Dorkoosh, S. Hosseinkhani, T. Amini, A. A. Rahimi, A. Rouholamini Najafabadi
and M. Rafiee Tehrani
Stability studies of chitosan-DNA-FAP-B nanoparticles for
gene delivery to lung epithelial cells. . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . .83
P. K. Pawar, R. Katara and D. K. Majumdar
Design and evaluation of moxifloxacin hydrochloride ocular insert. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
SHORT COMMUNICATIONS
S. C. Dadarwal, S. Madan and S. S. Agrawal
Formulation
and evaluation of delayed-onset extended-release tablets of metoprolol tartrate
using hydrophilic-swellable polymers. . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
V. Bačić Vrca, Lj. Mayer, F.
Škreb, D. Rahelić and S. Marušić
Antioxidant
supplementation and serum lipids in patients with Graves' disease: Effect on
LDL-cholesterol. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
115